MedPath

Joint distraction in the treatment of knee osteoarthritis; long-term efficacy (pilot)

Completed
Conditions
joint destruction
osteoarthritis
10023213
Registration Number
NL-OMON38528
Lead Sponsor
niversitair Medisch Centrum Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
6
Inclusion Criteria

Six patients from the pilot phase of the performed feasibility studies (n<=3 in #01/146 and n<=3 in #04/086).

Exclusion Criteria

NA

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Daily function based on the questionnaire according to Van Valburg (Van Valburg<br /><br>et al. JBJS 1995; 77: 720-5).</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Pain according to a box scale (Van Valburg et al. JBJS 1995; 77: 720-5)<br /><br>Joint space with, digitally measured on radiographs using KIDA (Marijnissen<br /><br>Osteoarthr Cartil 2008; 16: 234-243)<br /><br>Subchondral sclerosis, digitally measured on radiographs using KIDA<br /><br>(Marijnissen Osteoarthr Cartil 2008; 16: 234-243)<br /><br>Medical history using newly developed questionnaire<br /><br>Physical examination based on the questionnaire according to Van Valburg (Van<br /><br>Valburg et al. JBJS 1995; 77: 720-5).<br /><br>Cartilage volume measured on MRI, using the method of F. Eckstein (Burgkart<br /><br>Arthtitis Rheum 2001; 44: 2072-2077, Eckstein Arthritis Rheum 2005; 52:<br /><br>3132-3136, Buck Magn Reson Med 2010; 63: 680-690)<br /><br>Pain and function based on the WOMAC questionnaire (Bellamy J Rheumatol Suppl<br /><br>1995; 43: 49-51).</p><br>
© Copyright 2025. All Rights Reserved by MedPath